Results 1 to 10 of about 4,678 (246)

Post‐radiotherapy cribriform‐morular thyroid carcinoma [PDF]

open access: yesJournal of Clinical Laboratory Analysis, Volume 37, Issue 1, January 2023., 2023
Abstract Background According to the new 2022 World Health Organization classification of endocrine tumors, thyroid malignancy, formerly known as the cribriform‐morular variant of papillary thyroid carcinoma, is now categorized as differentiated thyroid malignancy; it is, at present, called cribriform‐morular thyroid carcinoma and classified as a tumor
Arzu Or Koca, Gülçin Güler Şimşek
wiley   +2 more sources

Histon ELISA ve Nicel PCR Testlerinin Birleştirilerek Histon Metilasyonu ile İlişkili Dolaşımdaki DNA’nın İzolasyonu ve Ölçülmesi

open access: yesNamık Kemal Tıp Dergisi, 2022
Aim:Liquid biopsy-based measurement of post-translational histone modifications (PTHMs) in bodily fluids of patients with cancer represents a novel area of biomarker research.
Emre ÖZGÜR   +3 more
doaj   +1 more source

The Prognostic and Predictive Value of DR-70 Immunoassay, A Novel Fibrin-Associated Biomarker, in Patients with Advanced Gastrointestinal Cancers

open access: yesNamık Kemal Tıp Dergisi, 2022
Aim:DR-70 is a newly developed immunoassay that detects fibrin degradation products in blood. We aimed to evaluate ability of DR-70 in monitoring treatment response in advanced gastrointestinal (GI) cancers.Materials and Methods:We prospectively enrolled
Tuğba AKIN TELLİ   +11 more
doaj   +1 more source

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center

open access: yesNamık Kemal Tıp Dergisi, 2022
Aim:Medullary thyroid carcinoma (MTC) originating from parafollicular C cells is a sporadic endocrine tumor. A unique aspect of the disease is that it is 25% familial and component of multiple endocrine neoplasia 2 syndromes.
Ferhat FERHATOĞLU   +2 more
doaj   +1 more source

Meme Kanseri Hastalarımızın Retrospektif Analizi

open access: yesSakarya Tıp Dergisi, 2014
Meme kanseri kadınlarda en sık rastlanan kanserdir. Erken tanı yöntemlerinin gelişmesi ve tedavideki ilerlemelere rağmen halen önemli bir mortalite ve morbidite nedenidir.
Ali Tamer   +4 more
doaj   +1 more source

A COMPARATIVE STUDY OF CONVENTIONAL BLOOD CULTURE METHOD VS SEPSIS QPCR MX-30 ® PANEL IN PATIENTS WITH PEDIATRIC LEUKEMIA

open access: yesHematology, Transfusion and Cell Therapy, 2023
Objective: Acute leukemia is the most common pediatric hematological malignancy. Blood stream infections (BSI) are severe complications in these patients during chemotherapy.
F.Burçin Kurtipek   +6 more
doaj   +1 more source

Kanser Ağrısının Yönetiminde Bir Yaklaşım: Müzik Terapi

open access: yesAnkara Medical Journal, 2019
Kanser hastalarında, hastalık ilerledikçe ağrı sıklıkla gelişen bir semptomdur. Kanser ağrısı genellikle nosiseptif, nöropatik ve inflamatuar bileşenlere sahip olabilen karma bir etiyolojiye sahiptir. Kanserin tipine, evresine ve yayılmasına bağlı olarak
Esra Tayaz, Sevinç Kutluturkan
doaj   +1 more source

Investigation of the germline PALB2 variants in cancer patients using the next-generation sequencing in Türkiye

open access: yesAdıyaman Üniversitesi Sağlık Bilimleri Dergisi, 2023
Aim: The study aimed to investigate germline PALB2 gene variants in 1056 cancer patients in Türkiye, selected based on the National Comprehensive Cancer Network guidelines for genetic/familial high-risk assessment related to breast, ovarian, and ...
Seda Kılıç Erciyas   +5 more
doaj   +1 more source

ONKOLOJİ ALANINDA ÇALIŞAN HEMŞİRELERİN YERİNE GETİRDİKLERİ ROL VE İŞLEVLER

open access: yesHemşirelikte Araştırma Geliştirme Dergisi, 2010
Amaç: Kanser tüm dünyada olduğu gibi ülkemizde de önemli bir ölüm nedenidir. Kanser insidansının artması onkoloji hemşireliğinin gelişimini de etkilemiştir. Bu araştırma onkoloji alanında çalışan hemşirelerin eğitim, araştırma ve
Hayriye Ünlü   +3 more
doaj   +1 more source

Efficacy Comparison Between Weekly and Triweekly Regimens of Carboplatin-paclitaxel in Non-small Cell Lung Cancer

open access: yesNamık Kemal Tıp Dergisi, 2023
Aim:Around 40% of non-small cell lung cancers have stage 3b or 4 disease at the time of diagnosis. In the treatment, platinum-based therapy can still be used in patients who do not carry a driver mutation or who are not suitable for immunotherapy with ...
Serdar ATA   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy